By MYER LEE The Daily News Dec 13, 2020 Darrell Carney’s company, Chrysalis BioTheraputics, received $10.4 million to continue developing TP508, a drug that remedies the effects of radiation exposure. …
December 01, 2020 09:10 AM Eastern Standard Time GALVESTON, Texas--(BUSINESS WIRE)--Chrysalis BioTherapeutics, Inc., a clinical-stage biotechnology company focused on the development of regenerative medicines to save lives, announced today that…
We answer all email and requests as they come in. If you have an urgent matter or would like to place an order please click the link below to give us a call.
Chrysalis BioTherapeutics, Inc. is committed to helping improve people’s lives through innovation.